Sorafenib Therapy in High Risk OLT Recipients with HCC

Investigator: Rafik Ghobrial, MD

Study Coordinator: Susan Dorman

Status: Enrolling Number: NCT01624285

Phone: 713.441.6316

IRB Number: Pro00008131


The purpose of this study is to determine if sorafenib (sorafenib tosylate) is a safe and effective treatment option for preventing liver cancer in high risk patients following liver transplantation. Liver transplantation is a treatment option for liver cancer patients, but despite transplantation, the liver cancer can recur in the new, transplanted liver. It is not known whether sorafenib is effective in preventing cancer recurrence in high risk patients following liver transplantation
More to Explore